These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Angiogenesis--principles and significance in urologic tumors]. Strohmeyer D; Strohmeyer T Urologe A; 1996 Sep; 35(5):357-62. PubMed ID: 8999626 [TBL] [Abstract][Full Text] [Related]
3. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. O'Reilly MS EXS; 1997; 79():273-94. PubMed ID: 9002223 [TBL] [Abstract][Full Text] [Related]
5. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. O'Reilly MS; Holmgren L; Shing Y; Chen C; Rosenthal RA; Cao Y; Moses M; Lane WS; Sage EH; Folkman J Cold Spring Harb Symp Quant Biol; 1994; 59():471-82. PubMed ID: 7587101 [No Abstract] [Full Text] [Related]
6. A new approach to fighting cancer? Sato TN Proc Natl Acad Sci U S A; 1998 May; 95(11):5843-4. PubMed ID: 9600880 [No Abstract] [Full Text] [Related]
7. Thrombospondin as a regulator of angiogenesis. DiPietro LA EXS; 1997; 79():295-314. PubMed ID: 9002224 [No Abstract] [Full Text] [Related]
9. [Angiostatin. A biological inhibitor of tumor angiogenesis]. Thimme R; Spangenberg HC; Blum HE Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915 [No Abstract] [Full Text] [Related]
10. Are angiostatin and endostatin cures for cancer? Harris AL Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709 [No Abstract] [Full Text] [Related]
11. Angiogenesis and surgery: from mice to man. Drixler TA; Voest EE; van Vroonhoven TJ; Borel Rinkes IH Eur J Surg; 2000 Jun; 166(6):435-46. PubMed ID: 10890539 [No Abstract] [Full Text] [Related]
12. The implications of angiogenesis for the biology and therapy of cancer metastasis. Fidler IJ; Ellis LM Cell; 1994 Oct; 79(2):185-8. PubMed ID: 7525076 [No Abstract] [Full Text] [Related]
13. Angiostatin: candidate for molecule of the year! Shanahan F; O'Sullivan GC Gastroenterology; 1995 Jun; 108(6):1946-8. PubMed ID: 7539391 [No Abstract] [Full Text] [Related]
14. New perspectives in clinical oncology from angiogenesis research. Folkman J Eur J Cancer; 1996 Dec; 32A(14):2534-9. PubMed ID: 9059344 [No Abstract] [Full Text] [Related]
15. [Opening to the age of regenerative medicine--the mechanism of angiogenesis]. Murota S Kokubyo Gakkai Zasshi; 2002 Jun; 69(2):81-8. PubMed ID: 12136664 [No Abstract] [Full Text] [Related]
16. The mechanism of action of angiostatin: can you teach an old dog new tricks? Moser TL; Stack MS; Wahl ML; Pizzo SV Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069 [TBL] [Abstract][Full Text] [Related]
17. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. Bornstein P J Cell Biol; 1995 Aug; 130(3):503-6. PubMed ID: 7542656 [No Abstract] [Full Text] [Related]
18. A cancer therapy resistant to resistance. Kerbel RS Nature; 1997 Nov; 390(6658):335-6. PubMed ID: 9389468 [No Abstract] [Full Text] [Related]
19. Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments. Cao Y Prog Mol Subcell Biol; 1998; 20():161-76. PubMed ID: 9928530 [No Abstract] [Full Text] [Related]
20. Angiogenesis as a target for cancer therapy. Kaban K; Herbst RS Hematol Oncol Clin North Am; 2002 Oct; 16(5):1125-71. PubMed ID: 12512387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]